Varex Imaging CorpVREXEarnings & Financial Report
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
VREX Q1 FY2026 Key Financial Metrics
Revenue
$209.6M
Gross Profit
$69.8M
Operating Profit
$15.4M
Net Profit
$2.3M
Gross Margin
33.3%
Operating Margin
7.3%
Net Margin
1.1%
YoY Growth
4.9%
EPS
$0.05
Varex Imaging Corp Q1 FY2026 Financial Summary
Varex Imaging Corp reported revenue of $209.6M (up 4.9% YoY) for Q1 FY2026, with a net profit of $2.3M (up 866.7% YoY) (1.1% margin). Cost of goods sold was $139.8M, operating expenses totaled $54.4M.
Key Financial Metrics
| Total Revenue | $209.6M |
|---|---|
| Net Profit | $2.3M |
| Gross Margin | 33.3% |
| Operating Margin | 7.3% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Varex Imaging Corp Q1 FY2026 revenue of $209.6M breaks down across 2 segments, led by Medical Segment at $144.8M (69.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Medical Segment | $144.8M | 69.1% |
| Industrial Segment | $64.8M | 30.9% |
Varex Imaging Corp Revenue by Segment — Quarterly Trend
Varex Imaging Corp revenue by segment across the last 4 reported quarters, showing how each business line (such as Medical Segment and Industrial Segment) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Medical Segment | $144.8M | $152.1M | $142.1M | $153.8M |
| Industrial Segment | $64.8M | $76.8M | $60.9M | $59.1M |
Varex Imaging Corp Annual Revenue by Year
Varex Imaging Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $844.6M).
Varex Imaging Corp Quarterly Revenue & Net Profit History
Varex Imaging Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $209.6M | +4.9% | $2.3M | 1.1% |
| Q4 FY2025 | $228.9M | +11.3% | $12.2M | 5.3% |
| Q3 FY2025 | $203.0M | -2.9% | $-89.1M | -43.9% |
| Q2 FY2025 | $212.9M | +3.2% | $6.9M | 3.2% |
| Q1 FY2025 | $199.8M | +5.2% | $-300.0K | -0.2% |
| Q4 FY2024 | $205.7M | -9.5% | $-51.1M | -24.8% |
| Q3 FY2024 | $209.1M | -9.9% | $1.4M | 0.7% |
| Q2 FY2024 | $206.2M | -9.6% | $1.4M | 0.7% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $206.2M | $209.1M | $205.7M | $199.8M | $212.9M | $203.0M | $228.9M | $209.6M |
| YoY Growth | -9.6% | -9.9% | -9.5% | 5.2% | 3.2% | -2.9% | 11.3% | 4.9% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.25B | $1.25B | $1.21B | $1.33B | $1.36B | $1.07B | $1.11B | $1.10B |
| Liabilities | $661.5M | $657.4M | $670.4M | $778.0M | $793.7M | $603.9M | $620.8M | $607.2M |
| Equity | $576.1M | $581.2M | $529.1M | $540.2M | $549.7M | $455.3M | $472.6M | $476.9M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.1M | $8.0M | $25.9M | $9.5M | $16.6M | $7.7M | $7.9M | $-16.1M |